Exact FDA event identifier

Event 96073

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: December 27, 2024
Product types: Drug
Classifications: Class II
Statuses: Ongoing
Recalling firm wording: Eugia US LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

D-0186-2025

Recall number: D-0186-2025
Initiated: December 27, 2024
Classification: Class II
Status: Ongoing
Recalling firm: Eugia US LLC
Quantity: 17,300 10-mL vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0

Particulate Matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

Code information

Batch # 1PR24010, Expiry: 02/28/2027

Distribution pattern

Distributed Nationwide in the USA.